Aquinox Pharma's bladder pain drug fails to meet study goal

(Reuters) - Aquinox Pharmaceuticals Inc said on Wednesday its treatment for bladder pain syndrome failed to meet the main goal of a late-stage trial, and the company plans to stop developing the drug.